Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
DEXTROSE INJECTION USP PFIZER CANADA ULC Actual shortage 500MG Updated Report 2022-09-25 168306
NALCROM SANOFI-AVENTIS CANADA INC Resolved 100MG Updated Report 2022-09-24 163129
METHOTREXATE INJECTION USP PFIZER CANADA ULC Actual shortage 25MG Updated Report 2022-09-24 165286
MEPRON GLAXOSMITHKLINE INC Actual shortage 750MG Updated Report 2022-09-24 170088
STIEVA-A GLAXOSMITHKLINE INC Actual shortage 0.05% Updated Report 2022-09-24 170091
BIPHENTIN ELVIUM LIFE SCIENCES Resolved 20MG Updated Report 2022-09-24 165716
BIPHENTIN ELVIUM LIFE SCIENCES Resolved 15MG Updated Report 2022-09-24 169311
ERYTHROCIN I.V. AMDIPHARM LIMITED Actual shortage 500MG Updated Report 2022-09-24 169767
ERYTHROCIN I.V. AMDIPHARM LIMITED Actual shortage 1G Updated Report 2022-09-24 169775
COTAZYM ORGANON CANADA INC. Actual shortage 35000UNIT 40000UNIT 10000UNIT Updated Report 2022-09-24 170162

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
EGRIFTA THERATECHNOLOGIES INC To be discontinued 1MG New Report 2022-09-22 170025
STAXYN BAYER INC Reversed 10MG Updated Report 2022-09-19 163103
JAMP-SILDENAFIL JAMP PHARMA CORPORATION Discontinued 50.0MG New Report 2022-09-09 169006
JAMP-SILDENAFIL JAMP PHARMA CORPORATION Discontinued 25.0MG New Report 2022-09-09 169003
JAMP-RIZATRIPTAN IR JAMP PHARMA CORPORATION Discontinued 10MG New Report 2022-09-09 168998
JAMP-RIZATRIPTAN IR JAMP PHARMA CORPORATION Discontinued 10MG New Report 2022-09-09 168995
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 12.5MG 50MG New Report 2022-09-09 168990
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 12.5MG 50MG New Report 2022-09-09 168987
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 25MG 100MG New Report 2022-09-09 168984
JAMP-LOSARTAN HCTZ JAMP PHARMA CORPORATION Discontinued 25MG 100MG New Report 2022-09-09 168981
DITROPAN XL JANSSEN INC Discontinued 10MG Updated Report 2022-09-08 155636
DITROPAN XL JANSSEN INC Discontinued 5MG Updated Report 2022-09-08 155633
NOVOLIN GE 50/50 PENFILL NOVO NORDISK CANADA INC To be discontinued 50UNIT 50UNIT New Report 2022-09-07 168747
NOVOLIN GE 40/60 PENFILL NOVO NORDISK CANADA INC To be discontinued 60UNIT 40UNIT New Report 2022-09-07 168714
APO-CLOBETASOL SPRAY APOTEX INC Discontinued 0.05% New Report 2022-09-06 168648
HUMULIN N ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2022-09-02 156217
SANDOZ PIOGLITAZONE SANDOZ CANADA INCORPORATED Discontinued 45MG Updated Report 2022-09-02 168487
DIAMICRON SERVIER CANADA INC To be discontinued 80MG New Report 2022-08-31 168298
ENBREL IMMUNEX CORPORATION To be discontinued 1ML 25MG New Report 2022-08-29 168157
ZOFRAN NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 4MG Updated Report 2022-08-29 163685